Nuvation Bio Inc reports results for the quarter ended in March - Earnings Summary

Nuvation Bio

08/05/2023 13:01

* Nuvation Bio Inc  NUVB.N  reported a quarterly adjusted
loss
of 10 cents​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 10
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Nuvation Bio Inc's reported EPS for the quarter was a loss
of 10
cents​.
    * The mean earnings estimate of analysts had risen by
about 7.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Nuvation Bio Inc shares had risen by 0.6% this quarter and
lost 13.0% so far this year.
    * The company reported a quarterly loss of $21.73 million.
    * Wall Street's median 12-month price target for Nuvation
Bio Inc
is $4.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
8 at 12:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.10          -0.10          Met
 Dec. 31 2022      -0.11          -0.10          Beat
 Sep. 30 2022      -0.14          -0.12          Beat
 Jun. 30 2022      -0.13          -0.16          Missed